Does surgery before In Vitro Fertilization (IVF) improve outcomes?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 18, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Surgery Before IVF: Evidence-Based Recommendations

Surgery before IVF does not improve outcomes for most infertile women and may actually harm ovarian reserve, with the notable exception of submucosal fibroids where hysteroscopic myomectomy significantly improves pregnancy rates. 1

Endometriosis and Endometriomas: Surgery Not Recommended

For women with endometriomas planning IVF, surgery should be avoided as it does not improve pregnancy outcomes and significantly reduces ovarian reserve. 2

Key Evidence Against Surgery for Endometriomas

  • Women with endometriomas have similar live birth rates (OR 0.98; 95% CI [0.71,1.36]) and clinical pregnancy rates (OR 1.17; 95% CI [0.87,1.58]) compared to women without endometriomas undergoing IVF. 2

  • Surgical removal of endometriomas before IVF yields similar live birth rates (OR 0.90; 95% CI [0.63,1.28]), similar clinical pregnancy rates (OR 0.97; 95% CI [0.78,1.20]), and similar oocyte retrieval numbers compared to no surgery. 2

  • Surgery for endometriomas is deleterious to ovarian reserve and function, with convincing evidence showing no additional fertility benefits. 3

  • Post-surgical complications include higher risk of premature ovarian failure, earlier menopause, higher IVF cycle cancellation rates, and reduced ovarian response to gonadotropins. 3, 4

Limited Exceptions When Surgery May Be Justified

Surgery for endometriomas should only be considered in these specific circumstances:

  • Severe dysmenorrhea significantly impacting quality of life 5
  • Suspected malignancy requiring tissue diagnosis 5
  • Very large endometriomas (>6 cm) that physically impede follicle access during oocyte retrieval 5
  • Very large endometriomas preventing adequate ovarian response to controlled ovarian stimulation 5

Deep Endometriosis: Insufficient Evidence

  • One meta-analysis showed higher pregnancy rates per patient and live birth rates in women who underwent surgery for deep endometriosis before IVF compared to those without surgery. 6

  • However, available data are insufficient to recommend surgical excision of deep endometriosis as first-line treatment for asymptomatic patients to enhance IVF outcomes. 6

  • Prolonged pituitary downregulation (GnRH agonist protocol) in women with surgically diagnosed endometriosis may increase clinical pregnancy rates in subsequent IVF cycles. 5

Uterine Fibroids: Surgery Depends on Location

Submucosal Fibroids: Surgery Strongly Recommended

Hysteroscopic myomectomy is the treatment of choice for submucosal fibroids before IVF, as these fibroids have the most detrimental effect on fertility with pregnancy rates of only 10% and implantation rates of 4.3%. 1

  • After hysteroscopic myomectomy, pregnancy rates improve to 85% with live birth rates of 65%. 1

  • The procedure offers shorter hospitalization and faster recovery compared to other surgical approaches. 1

Intramural Fibroids: Consider Surgery

  • Intramural fibroids significantly reduce pregnancy rates (16.4%) and implantation rates (6.4%) compared to women without fibroids, even without cavity distortion. 1

  • Surgical treatment should be considered before ART treatment, though evidence is less clear than for submucosal fibroids. 1

  • Laparoscopic or open myomectomy are options with similar pregnancy and live birth rates. 1

Subserosal Fibroids: Surgery Not Indicated

  • Subserosal fibroids do not significantly impact fertility, with pregnancy rates (34.1%) and implantation rates (15.1%) similar to women without fibroids (30.1% and 15.7% respectively). 1

Large Fibroids (20-Week Size)

  • Open myomectomy is preferred over laparoscopic approaches for very large uteri or multiple fibroids, offering better access and outcomes. 1

  • Combined miscarriage rate after myomectomy (14%) is comparable to the general population. 1

  • Uterine artery embolization is not recommended for women desiring fertility due to increased risks of miscarriage (35%), cesarean sections (66%), and postpartum hemorrhage (13.9%). 1

Other Surgical Considerations

Ovarian Transposition (Oophoropexy)

  • For women requiring pelvic radiation, oophoropexy has uncertain fertility outcomes with approximately 50% pregnancy success rate due to scatter radiation, altered ovarian blood supply, and fallopian tube damage. 7

Fertility-Sparing Gynecologic Surgery

  • Trachelectomy (cervical removal while preserving uterus) is appropriate for early-stage cervical cancer with no evidence of higher cancer relapse rates in appropriate candidates. 7

  • Conservative gynecologic surgery should minimize normal tissue resection when oncologically safe. 7

Common Pitfalls to Avoid

  • Do not delay IVF for endometrioma surgery unless one of the specific exceptions listed above applies—surgery extends time to pregnancy without improving outcomes. 3

  • Do not perform bilateral endometrioma surgery or repeat surgical procedures, as these dramatically worsen ovarian reserve. 6

  • Do not use GnRH agonists for ovarian protection during chemotherapy as they do not reliably preserve fertility despite some improvement in menstrual recovery. 8

  • Always perform transvaginal ultrasound to accurately classify fibroids as subserosal, intramural, or submucosal before making surgical decisions. 1

References

Guideline

Management of Uterine Fibroids in Infertile Women

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Is there a benefit for surgery in endometrioma-associated infertility?

Current opinion in obstetrics & gynecology, 2012

Research

Impact of surgery for endometriosis on the outcomes of in vitro fertilization.

Best practice & research. Clinical obstetrics & gynaecology, 2024

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Oocyte Development and Stimulation in Fertility Treatments

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.